Details

Last Funding Type

Series D

Last Funding Money Raised

$32M

Industries

Advanced Materials

Founded date

Jan 1, 1998

Number Of Employee

101 - 250

Operating Status

Active

Genicon Sciences is engaged in the rapid commercialization of its integrated RLS-based assay toolkits, instrumentation and software products, services and solutions that meet the needs of the life sciences research community. Our proprietary Resonance Light Scattering (RLS) Technology, is a non-fluorescent, broadly applicable, ultra-sensitive signal generation and detection technology that enables the measurement of a wide range of bioassays with unprecendented accuracy and reproducibility.

Committed to the rapid and widespread adoption of RLS Technology, Genicon provides researchers with open access to the superior signal generation and detection results achieved using its integrated RLS assay toolkits, instrumentation and software products, while leveraging the infrastructure of its channel distributors, value added resellers and research and development collaborators for rapid commercial deployment. Genicon's goal is to provide the highest quality products and unparalleled customer service by instilling confidence and certainty of scientific outcomes in a credible and consistent manner.